WO2009066995A2 - Dispositif implantable - Google Patents

Dispositif implantable Download PDF

Info

Publication number
WO2009066995A2
WO2009066995A2 PCT/MY2008/000161 MY2008000161W WO2009066995A2 WO 2009066995 A2 WO2009066995 A2 WO 2009066995A2 MY 2008000161 W MY2008000161 W MY 2008000161W WO 2009066995 A2 WO2009066995 A2 WO 2009066995A2
Authority
WO
WIPO (PCT)
Prior art keywords
sensor
implantable device
designed
wearer
micro
Prior art date
Application number
PCT/MY2008/000161
Other languages
English (en)
Other versions
WO2009066995A3 (fr
Inventor
Nor Md Rihan Bin Md Daim
Original Assignee
Mimos Berhad
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimos Berhad filed Critical Mimos Berhad
Publication of WO2009066995A2 publication Critical patent/WO2009066995A2/fr
Publication of WO2009066995A3 publication Critical patent/WO2009066995A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/38—Applying electric currents by contact electrodes alternating or intermittent currents for producing shock effects
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4833—Assessment of subject's compliance to treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/02—Operational features
    • A61B2560/0204—Operational features of power management
    • A61B2560/0214—Operational features of power management of power generation or supply
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0031—Implanted circuitry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/07—Endoradiosondes
    • A61B5/076—Permanent implantations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
    • A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
    • A61N1/36082—Cognitive or psychiatric applications, e.g. dementia or Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/37205—Microstimulators, e.g. implantable through a cannula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372—Arrangements in connection with the implantation of stimulators
    • A61N1/378—Electrical supply

Definitions

  • the present invention relates to the use of an implantable device comprises of a combination of multiple apparatus and system for chemical(s) detection.
  • Drug addiction is one of the major problems in many countries around the world including Malaysia. To overcome this problem, our government has invested millions of ringgit every year by setting up and maintaining the "Pusat Serenti", rehabilitation center and other anti-drug programs. Besides the involvement of government agencies, the non-governmental organizations (NGOs) have also tried several methods including campaign, counseling, advertisement and other activities to create awareness to the public. However, the results are disappointing because it is difficult to rehabilitate and monitor the drug addicts at all time.
  • an implantable device comprising of a combination of multiple apparatus and system for chemical(s) detection, for example, an anti drug device is designed to be implanted inside the drug addict's and patient's body, which has an embedded chemical sensor system for detecting the presence of chemicals such as drugs.
  • the invention comprises of a micro stun gun wherein the said stun gun will be activated and electric shocks will be generated upon detection of certain chemicals. The shock is designed not to threaten the wearer's life. The purpose of this device is to give warning or punishment to the wearer and/or patient and to deter the wearer from taking any more drugs.
  • US 4,868,545 discloses an invention that relates to an apparatus for detecting the presence of alcohol in expired breath in the atmosphere, comprising a gas sampler, a detector for the presence of alcohol in a gas sample, an output indicator or recorder coupled to the detector to provide an output signal when alcohol is detected, and an automatic controller for actuating the sampler and detector in response to a signal from a sensor arranged to be responsive to the presence of a subject to be tested.
  • United States granted patent No. US 7,033,322 B2 discloses a sensor for implantation within a blood vessel to monitor glucose levels. A signal indicative of glucose level is transmitted to an external receiver. The signal may also be used to drive an internal or externally worn insulin pump.
  • United States patent application No. US 2007/0065363 Al discloses generally a drug management system and methods for assessing a patient's hemodynamic response to a drug therapy, more particularly, to quantifying a patient's hemodynamic response to a drug therapy using sensor data acquired via medical device, such as an implantable medical device.
  • the patient's hemodynamic response to the drug therapy is quantified, such as by quantifying a patient's sensitivity or refractoriness to the drug therapy.
  • the quantified data may be used to optimize a patient's drug therapy, among other uses.
  • the implantable device for detecting the presence of one or more chemical compounds wherein the compounds are drugs, alcohol and other chemical compounds.
  • the implantable device comprises of a micro stun gun (1), rechargeable battery and rechargeable power supply (2), battery charger and power supply charger (3), memory and storage system (4), data processor (5), health sensor system (6), chemical sensor system (7) and/or antenna and communication system (8).
  • the implantable device can be implanted in blood vessel (9), tissue, organ and body.
  • the micro stun gun (1) is programmable and is designed to deliver electric shocks.
  • the micro stun gun (1) may be calibrated according to the health condition of the wearer.
  • the electric shocks generated by the micro stun gun (1) causes muscle cramp and pain in the body.
  • the rechargeable battery and rechargeable power supply (2) is designed to store electric power and to supply electric power to the needed apparatus or systems.
  • the battery charger and power supply charger (3) is designed to generate electricity from kinetic energy, mechanical energy from environmental sources such as ultrasonic waves, mechanical vibration or blood flow, blood cycle to spin a micro turbine to charge the battery. Electricity can also be generated from vibration such as from heart beat and nerve pulse, frequency such as radio frequency, and other suitable techniques to integrate and generate electricity.
  • the memory and storage system (4) is designed to store information for operation purposes, to prepare reports and to accept new order and instructions, The memory and storage system (4) is also designed for programming and upgrading of system, for wearer identification and etc.
  • the data processor (5) is designed to process data and information detected by the sensor systems and to activate or deactivate the micro stun gun (1).
  • the data processor (5) is also designed to differentiate the type, quantity and quality of the chemicals, and to protect and secure the objectives and functions of the device.
  • the health sensor system (6) is designed to detect the health conditions of the individual wearer and enable the data processor to activate or deactivate the micro stun gun (1).
  • the health sensor system (6) may incorporates sensor or sensors for example the heart scanner, insulin/glucagon sensor, thermometer, blood pressure sensor and any other sensors to monitor health condition of the wearer.
  • the (7) is designed to detect the type, quantity and quality of the chemicals.
  • the chemical sensor system (7) incorporates sensor or sensors for example drug sensor, alcohol sensor, allergy sensor and etc.
  • the antenna and communication system (8) is designed to communicate through the satellite and communication tower, to communicate to the other anti drug devices as well as other external devices, such as a control room and central control device.
  • the antenna and communication system (8) is also designed to locate the wearer, for receiving and sending of data.
  • the antenna and communication system (8) incorporates wireless technology, Global Positioning System (GPS) technology and any other suitable communication technologies.
  • Figure 1 illustrates the main components of the implantable device.
  • Figure 2 illustrates the main components of the implantable device wherein the chemical sensor system (7) is implanted in the blood vessel (9).
  • Figure 3 is a block diagram illustrating the operation system of the implantable device.
  • the present invention relates to an implantable device, i.e. an anti drug device which can be implanted inside the wearer's body.
  • the implantable device comprises of a micro stun gun (1), rechargeable battery and rechargeable power supply (2), battery charger and power supply charger (3), memory and storage system (4), data processor (5), health sensor system (6), chemical sensor system (7) and/or antenna and communication system (8).
  • the implantable device can be implanted in the blood vessel (9), tissue, organ and body.
  • the embedded chemical sensor system (7) can be used to detect the presence of chemicals such as drugs in the blood stream.
  • the data processor (5) subsequently will process the information detected by the chemical sensor system (7) and the wearer's health condition detected by the health sensor system (6) simultaneously.
  • the data processor (5) will make appropriate judgement in the activation or deactivation of micro stun gun (1) wherein the result or information as detected by both the sensor systems will be processed and analyzed before the activation or deactivation of micro stun gun (1). For example, if the wearer is unhealthy, the health sensor system is able to detect such a condition and automatically terminate the activation of micro stun gun (1) in order to avoid severe injury to the wearer. If the wearer is healthy, the micro stun gun (1) will be activated and the device will generate a predetermined amount of electric shocks when it senses certain amount of drugs in the body. The shock is designed not to threaten the wearer's life. The purpose of this device is to give warning or punishment to the wearer and to deter the wearer from taking or injecting more drugs.
  • the device will proceed to generate more and more intense electric shocks to the wearer in order to stop or to deter the wearer from consuming more drugs.
  • the system will only terminate generating the electric shocks when the level of the drugs returned to an acceptable level or when the health sensor system detects that the wearer's health condition is unable to safely withstand the electric shocks.
  • the wearer's drugs activity or record is recorded in the memory and storage system (4) wherein respective authority may collect the data to study or analyze and make necessary improvement on the system.
  • the anti drug device is able to detect and contact other anti drug devices within a certain radius, for example 20 meter square via antenna and communication system (8).
  • the implantable device is a platform wherein variation in the use of sensor or sensors may alter and affect the objectives and functions of the device.
  • the micro stun gun (1) is designed to deliver electric shocks which may caused muscle cramp and painful sensations in the body.
  • the micro stun gun (1) may be controlled using an electronic device and will perform as programmed.
  • the rechargeable battery and rechargeable power supply (2) is designed to store electric power and to supply electric power to the apparatus or systems.
  • the battery charger and power supply charger (3) is designed to generate electricity from kinetic energy, mechanical energy from environmental sources such as ultrasonic waves, mechanical vibrations or blood flow, blood cycle to spin a micro turbine to charge the battery. Electricity can also be generated from vibrations such as from heart beat and nerve pulse, frequency such as radio frequency, and other suitable techniques.
  • the memory and storage system (4) is designed to store information for operation purposes, to prepare reports, to accept new orders and instructions, for programming and upgrading of system, for wearer identification and etc.
  • the data processor (5) is designed to process data detected by the sensor systems, for example drug sensor, alcohol sensor, heart scanner, insulin/glucagon sensor, thermometer and blood pressure sensor.
  • the data processor (5) is able to differentiate the type, quantity and quality of the chemicals, for example, the types of drugs and alcohol as well as the quantities consumed.
  • a security system may be incorporated into the data processor to protect from any unauthorized access and from being tampered.
  • the health sensor system (6) incorporates multiple sensors for example the heart scanner, insulin/glucagon sensor, thermometer, blood pressure sensor and any other sensors to detect and monitor health condition of the wearer.
  • the sensor system is designed to detect the health conditions of the wearer and activate or deactivate the stun gun accordingly. If the wearer is unhealthy, the system is able to detect such a condition and automatically deactivates the micro stun gun in order to avoid severe injury to the wearer.
  • the chemical sensor system (7) incorporates multiple sensors for example drug sensor, alcohol sensor, allergy sensor and any other sensors that can be used to detect chemicals.
  • the sensor system is designed to detect the type, quantity and quality of the chemicals.
  • the antenna and communication system (8) has the ability to communicate through the satellite and communication tower.
  • the antenna and communication system (8) is designed to communicate to the other anti drug device, to communicate to the other external device, control room and central devices, to locate wearer, for receiving and sending of data, and etc.
  • This system incorporates wireless and Global Positioning System (GPS) technology.
  • GPS Global Positioning System

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Physics & Mathematics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Measuring And Recording Apparatus For Diagnosis (AREA)

Abstract

La présente invention concerne l'utilisation d'un dispositif implantable pour détecter la présence d'un ou de plusieurs composés chimiques, les composés pouvant être des médicaments, de l'alcool et d'autres composés chimiques. Le dispositif implantable comprend un micro-pistolet électrique (1), une batterie rechargeable et un dispositif d'alimentation électrique rechargeable (2), un chargeur de batterie et un chargeur d'alimentation électrique (3), une mémoire et un système de stockage (4), un processeur de données (5), un système de capteur d'état de santé (6), un système de capteur chimique (7) et/ou un système de communication et d'antenne (8).
PCT/MY2008/000161 2007-11-22 2008-11-24 Dispositif implantable WO2009066995A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
MYPI20072071 2007-11-22
MYPI20072071A MY155876A (en) 2007-11-22 2007-11-22 Implantable device

Publications (2)

Publication Number Publication Date
WO2009066995A2 true WO2009066995A2 (fr) 2009-05-28
WO2009066995A3 WO2009066995A3 (fr) 2009-10-15

Family

ID=40668029

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/MY2008/000161 WO2009066995A2 (fr) 2007-11-22 2008-11-24 Dispositif implantable

Country Status (2)

Country Link
MY (1) MY155876A (fr)
WO (1) WO2009066995A2 (fr)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5868142A (en) * 1994-05-06 1999-02-09 Carl Dahlborn Ab Implantable device
US20020198574A1 (en) * 2001-06-22 2002-12-26 Ron Gumpert Automatic sobriety training and reconditioning system
US20030158584A1 (en) * 2002-02-19 2003-08-21 Cates Adam W Chronically-implanted device for sensing and therapy
US20040080418A1 (en) * 2000-07-14 2004-04-29 Carl Dahlborn Method and device to prevent a person from using a drug

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5868142A (en) * 1994-05-06 1999-02-09 Carl Dahlborn Ab Implantable device
US20040080418A1 (en) * 2000-07-14 2004-04-29 Carl Dahlborn Method and device to prevent a person from using a drug
US20020198574A1 (en) * 2001-06-22 2002-12-26 Ron Gumpert Automatic sobriety training and reconditioning system
US20030158584A1 (en) * 2002-02-19 2003-08-21 Cates Adam W Chronically-implanted device for sensing and therapy

Also Published As

Publication number Publication date
WO2009066995A3 (fr) 2009-10-15
MY155876A (en) 2015-12-15

Similar Documents

Publication Publication Date Title
CN110536602B (zh) 牲畜健康监控系统和使用方法
US20040199056A1 (en) Body monitoring using local area wireless interfaces
EP3048971B1 (fr) Surveillance à distance d'alcool dans l'air expiré
US20080045932A1 (en) Unit Implantable Into a Living Body, Injection Medical System and Chronotherapeitic
CN103503041B (zh) 用于跌倒检测器或跌倒检测系统中的装置及其操作方法
US7619533B2 (en) Method and apparatus for monitoring persons
US20170172464A1 (en) Method for monitoring of activity and fall
CA2595401C (fr) Procede et dispositif de detection de chaleurs
US6490929B1 (en) Vibration dosimeter worn by an operator
US20030109988A1 (en) Three-dimensional GPS-assisted tracking device
US20110060252A1 (en) Monitoring Apparatus and Method
US8771201B2 (en) Health monitoring bolus
CN102665535A (zh) 连续的非干扰式健康监测与警报系统
CN107836024A (zh) 监测医疗设备的方法
CN102323984A (zh) 用于监控并分析体内用药方案的依从的方法与系统
KR20020072562A (ko) 모니터링 및 추적을 위한 시스템 및 방법
TWI577337B (zh) 皮下可植入式感測器裝置及相關系統與方法
WO2009066995A2 (fr) Dispositif implantable
US11269086B2 (en) System and method for radon detection
US20080077055A1 (en) Home suggested immobilization test (SIT) monitor and methodology
US6044293A (en) Method for detecting toxic chemical concentration in individuals
US20100228520A1 (en) activity monitor
BR112017005246B1 (pt) Dispositivo para monitorar indicadores de disfunção
CA2529545C (fr) Systeme et methode de surveillance d'activite et de chute
Hunkeler New generation of EM technology: Soon too many sensors?

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08852200

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08852200

Country of ref document: EP

Kind code of ref document: A2